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ABBREVIATIONS 
 
APC           - Adenomatous polyposis coli. 
CD44         -  Cluster of differentiation 44. 
D2              -  Second part of duodenum. 
HA             - Hyaluronic acid. 
HRP          -  Horse radish peroxidase. 
IARC        -  International Agency For Research On Cancer. 
IGFR II    -  Insulin like growth factor receptor 2 
IHC           -  Immunohistochemistry. 
LP             -  Lamina propria 
MD            -  Moderately differentiated adenocarcinoma. 
PBCR        -  Population Based Cancer Registries. 
PD             -  Poorly differentiated adenocarcinoma. 
RT-PCR   -  Real time polymerase chain reaction 
TGFβR II -  Transforming growth factor receptor 2 
TNM         -  Tumor Node And Metastasis. 
WD            -  Well differentiated adenocarcinoma. 
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INTRODUCTION 
 
Gastric carcinoma is the second most common malignancy among 
men and third most common among women in Asia and also worldwide (1). 
Frequency of gastric carcinoma varies much with different geographic 
locations. The symptoms and signs of the gastric carcinoma are often 
reported late when the disease is already in advanced stages (2). 
 
  Though the incidence of gastric carcinoma is decreasing nowadays, it 
is still the second leading cause of cancer related deaths (3). The major 
causes of mortality in case of gastric carcinoma even after a curative 
resection are recurrence and metastasis. The 5-year survival rate is less than 
30% in developed countries and around 20% in developing countries (4).  
 
Gastric adenocarcinoma comprises 95% of the total malignancies of 
stomach. Multiple genetic and epigenetic alterations are known to involve 
oncogenes, tumor suppressor genes, cell cycle regulators, cell adhesion 
molecules and are implicated in the multistep carcinogenesis of human 
gastric carcinoma(8).  
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HISTOLOGICAL AND ANATOMICAL CLASSIFICATION OF 
GASTRIC CANCER: 
Several classification systems have been proposed to delineate gastric 
cancer on the basis of both macroscopic as well as microscopic patterns of 
growth. Different classification system includes Borrman, Stout, Japanese 
system, Ming, World Health Organization (WHO) system and Lauren’s 
method. Of which WHO and Laurens are the two most commonly used 
classification systems (5). 
 
Treatment of choice for any resectable gastric cancer is, surgical 
therapy which could be total gastrectomy, subtotal gastrectomy or proximal 
gastrectomy. The choice of procedure depends on the location of tumor and 
the  ability to achieve tumor free surgical margins.  
 
The current TNM staging classified nodal metastasis based on number 
of positive nodes, in which it advocates a minimum of 15 lymph nodes to be 
resected and examined for staging to be accurate. Here comes the extended 
D2 resection procedure which offers better survival advantage compared 
with other surgical resections without lymphadenectomy(7). 
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Though with the availability of advanced methods of surgical 
techniques, it is still common to see patients with recurrence in many cases. 
 
Despite knowing that gastric carcinoma is not very sensitive to current 
chemotherapy agents, most of them are considered as palliative in order to 
reduce the tumor burden, to provide symptomatic relief and for better   
survival time. Post operative adjuvant chemotherapy can to some extent 
decrease the rate of recurrence.  
 
Though we know that gastric carcinoma is prone for recurrence, even 
with curative resection and modern chemotherapeutic drugs, no molecular 
biomarker is currently available to predict gastric carcinoma recurrence 
before / after resection. Frequent cause of death in gastric carcinoma are 
recurrence and metastasis.  
 
  Metastasis is initiated primarily by the loss of adhesion that renders 
the cancer cells to leave the site of origin, and subsequently reach the distant 
sites such as lymph nodes, liver, or the peritoneum to form secondary cell 
colonies (9). 
 
Interaction between the cells and also between the cell and the 
extracellular matrix is strictly regulated by cell adhesion molecules. Any 
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breakthrough in this property of cell adhesion molecules allow the process of 
tumor progression and metastasis(10). 
 
CD44 is a principal cell surface receptor for hyaluronic acid. 
Hyaluronic acid is a major component of extracellular matrix. Increased 
expression of CD44 by the tumor cells leads to avid binding with the 
hyaluronan in the matrix, thereby helping in communication of cell-matrix 
interactions into the cell which is known as outside-in signalling(10). 
 
CD44 plays a role in carcinogenesis, differentiation, as well as  lymph 
node metastasis which are considered to be prognostic for  carcinomas of 
various organs such as lung , breast , pancreas,  gastrointestinal tract 
including gastric cancer. It is considered as a determinant of metastatic and 
invasive behavior(11). 
 
As the literature suggests, CD44 is one of the factor that shows better 
association with initiation and progression of gastric cancer and also plays 
major role in diagnosis, therapy as well as in  prognosis.  The objective of 
this study is to identify the role of an adhesion protein CD44 in the genesis 
of gastric carcinoma. 
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The primary techniques that help to evaluate the presence and degree 
of CD44 expression are immunohistochemistry, fluorescence cell sorting, 
and reverse transcriptase polymerase chain reactions. 
 
Research on CD44 has been active but fragmented, and it may offer 
newer therapeutic approach to gastric cancer. 
 
While clinical predictive factors, such as tumor staging, can predict 
recurrence of advanced gastric cancer, some group of molecular-based 
biomarkers like CD44 which is a cell adhesion molecule can serve as a 
useful predictor for recurrence of advanced gastric cancer after curative 
resection and it has some possible predictive relevance in future clinical 
practice.  
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AIMS AND OBJECTIVES: 
 
1. To analyse age and sex distribution of gastric adenocarcinoma  
2. To analyse site of distribution of gastric adenocarcinoma. 
3. To assess the level of CD44 expression in gastric adenocarcinoma 
4. To evaluate the relation of cluster of differentiation 44 (CD44) 
expression with the pathological features like histological type, grade 
and stage of gastric adenocarcinoma.  
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  REVIEW OF LITERATURE 
Gastric carcinoma ranks second for cancer related mortality 
worldwide. 
HISTORICAL REVIEW: 
The word stomach is derived from the Latin name called ‘stomachus’. 
The stomach is a hollow muscular dilated region of the digestive system. It 
lies between the esophagus and the small intestine.  
The stomach lies below the diaphragm. The major part of stomach bed 
is formed by the pancreas. The greater curvature of the stomach is 
surrounded by the greater omentum. There are two sphincters which keep 
the contents of the stomach contained, esophageal sphincter dividing the 
digestive tract above, and the pyloric sphincter which divides the stomach 
from the small intestine.  
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STOMACH 
• Anatomically it is divided into 4 regions. They are cardia, fundus, body 
& antropyloric region.  
• Histologically the stomach is divided into 3 regions, which includes 
cardia, body and pylorus, because the fundus & the body have identical 
microscopic features. 
 
Layers of the stomach wall includes mucosa, submucosa, muscularis externa 
and serosa. 
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HISTOLOGY OF STOMACH 
MUCOSA 
Epithelium: Simple columnar lining epithelium that invaginates to variable 
extent into underlying lamina propria forming gastric pits. 
Lamina propria:  
Composed of loose connective tissue, and it is packed with glands. 
Muscularis mucosa:  Smooth muscle fibers.  
SUBMUCOSA 
Made of dense connective tissue, blood and lymph vessels as well as 
submucosal plexus of nerves, but absent glands. 
MUSCULARIS EXTERNA 
Characterized by 3 layers of smooth muscle which are inner-oblique, 
middle-circular & outer-longitudinal. In between the middle and outer 
muscular layers, lies myenteric plexus which innervates the wall. 
SEROSA  
Thin layer of connective tissue & mesothelium. 
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GASTRIC GLANDS are of 3 types based on the distribution and structural 
differences. They are cardia glands, fundic glands and pyloric glands. Each 
gland has 3 regions such as neck, isthmus (body) & base. Five types of cells 
which includes stem cells, mucus neck cells, parietal cells, chief cells and 
entero-endocrine cells are found in these glands. 
 
EPIDEMIOLOGY 
According to the World Health Organization, gastric carcinoma is the 
fourth most common malignancy worldwide, with gastric cancer cases 
accounting for the burden of around 8,70,000 new cases every year(16). 
Almost two-thirds of the cases occur in developing countries and 42% in 
China alone.  
 
The rate of occurrence of gastric cancer in different parts of world is 
as follows: 
INDIA          -8.9/100000 
USA             -10/100000 
JAPAN        -79.9/100000 
ENGLAND -18.5/100000. 
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This wide difference in incidence of gastric carcinoma in various 
geographic locations can be attributed to environmental factors and also due 
to differences in lifestyle and dietary habits. This property leads to division 
of high and low incidence areas for gastric carcinoma. Areas showing higher 
incidence includes East Asia (China, Japan) which accounts for major case 
percentage of 42% followed by Eastern Europe and also parts of Central and 
South America(18). 
Incidence rate in Chennai was 232 cases per 100,000 population and 
age standardised rate is around 12.3 and is more prevalent in age group of 
more than 60 years of age(18). Gastric cancer ranks first among males, but 
third among female cancers according to Chennai population based cancer 
registries(20). 
The age adjusted incidence rates for stomach cancer was found to be 
16.4 per 100000 male and 6.5 per 100000 female population based on 
Chennai PBCR(23).  
Despite newer surgical techniques and better chemotherapeutic 
agents, 40% of patients with advanced gastric cancer die of recurrence (17). 
The prognosis for patients after curative surgery still remains poor due to the 
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high recurrence rate. The 5-year survival rate for patients with post-resection 
status for gastric carcinoma  range from 47% to 60.4%. 
CLINICAL MANIFESTATIONS 
The symptoms are often non-specific in early stages of gastric 
carcinoma, due to which there is often delay in the diagnosis. Most common 
symptoms are anorexia, weight loss and abdominal pain.  
By the time, the signs and symptoms appear, the stage of gastric 
cancer would be advanced. Nausea, vomiting and early satiety occurs more 
commonly with bulky tumors that cause obstruction or infiltrative tumors 
that affects the normal distending capacity of the stomach. Ulcerated tumors 
may cause bleeding which may lead to hematemesis or malena(27). 
RISK FACTORS: 
Environmental factors play a major  role in the risk stratification  
among individuals. The role of H.pylori infection in pathogenesis of gastric 
carcinoma is well established by many studies. It is considered as 
carcinogenic in humans, as it is suggested by IARC.  
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High prevalence of gastric carcinoma within the population of lower 
socioeconomic status is certainly related to increased occurrence of H.Pylori 
infection in these people. 
  The Cag A gene (49) is the main virulence factor of H. pylori which is 
responsible for the development of gastric adenocarcinoma through the 
derangement of cellular architecture. The studies conducted in India showed 
high prevalence of H.Pylori which varies from 56-89% among cases of 
gastric carcinoma(4) and it also showed major association with lower 
socioeconomic status. 
Diet plays a major role in gastric carcinogenesis. Globally, literature 
suggests that none or low-starch vegetable is considered, the probable 
protective factor. In western diets where the animal foods and food 
preservatives are commonly used, there is increased risk of gastric 
carcinoma(21). 
Tobacco use in any form (chewing, smoking and drinking) was 
observed to increase the risk of stomach cancer in India. Smoking tobacco 
has been found to be an independent risk factor for stomach cancer. 
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Literature suggests that alcohol may be carcinogenic to the esophagus 
and cardia cancers but not to distal gastric cancer(22).  
 
MORPHOLOGY OF GASTRIC CARCINOMA 
 
Gross appearance of gastric cancer varies and can be either 
polypoidal, fungating, ulcerative or scirrhous.  
 
Polypoidal and fungating type of tumors tend to produce intraluminal 
mass. Polypoid tumors generally are not ulcerated; but the fungating tumors 
are ulcerated.  
 
In the other two gross forms of tumor such as ulcerative and scirrhous 
type, the bulk of the tumor mass is in the wall of the stomach.  
 
Scirrhous tumors which are otherwise called as “Linitis Plastica” tend 
to infiltrate the entire thickness of wall of the stomach leading to leather 
bottle appearance. It has particularly poor prognosis, and commonly involve 
the entire stomach. 
28 
 
CLASSIFICATIONS OF GASTRIC CARCINOMA 
Many classification systems of gastric carcinoma has been proposed 
based on tumor location, invasiveness, degree of differentiation, growth 
pattern and histological features. 
Based on tumor location it is divided into cardia and non-cardia 
cancers of stomach. These two anatomical subtypes show remarkable 
epidemiological and etiological differences. 
 
Non-cardia cancer is the predominant type seen in high risk areas and 
generally thought to arise due to the interaction between environment, host 
and H. pylori factors. But the cardia gastric cancer is more homogenously 
distributed throughout the world and develops by two major etiological 
mechanisms -atrophic gastritis and intestinal metaplasia. Though the overall 
incidence is declining, the cancer of gastric cardia is on the rise. 
 
Based on invasiveness, it is classified into two types as early gastric 
cancer  and late gastric cancer. 
In early type, invasion is restricted to submucosa, which is further 
subdivided into intramucosal and submucosal types. In the late type, 
invasion of muscularis externa is present. 
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Based on the degree of differentiation, gastric adenocarcinoma is 
divided into three types as well differentiated, moderately differentiated 
and poorly differentiated adenocarcinoma (classified based on the 
proportion of resemblance of tumor to the normal counterpart). In general 
the degree of gland formation is widely regarded as most important feature 
in grading. 
 In well differentiated adenocarcinoma, >95% of tumor is composed 
of well developed tubular glands with uniform cytological features. In 
moderately differentiated adenocarcinoma, complex glands with cribriform 
pattern is seen in around 50-95% of tumor cell population. In poorly 
differentiated adenocarcinoma, solid nests of cells, single cells, and signet 
ring cells with variable cytological abnormalities are seen (<49% of tumor 
composed of glands). 
This system is simple and reproducible but may be difficult to apply 
because of morphological heterogeneity within the same tumor present in 
many neoplasms. 
Based on the growth pattern, gastric carcinoma is divided into two types as 
expansile and infiltrative types.  
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The expansile type of tumors, grow as cohesive cell groups but the 
infiltrative tumors tend to show a diffusely infiltrative edge. 
Most important among these systems are WHO and Laurens 
classification system.  
WHO(19) categorises the grades to adenocarinoma based on the 
degree of resemblance to metaplastic intestinal tissue, by which it identifies 
5 major subtypes of adenocarcinoma(24) like adenocarcinoma (intestinal, 
diffuse type), papillary, mucinous and signet ring cell carcinoma type. 
Laurens has classified gastric carcinoma as intestinal and diffuse 
types-which shows difference in both geographic as well as histologic 
features(6). The morphological difference in these two types are attributed to 
intercellular adhesion molecules which are very well preserved in intestinal 
type rather than diffuse type of gastric carcinoma where there is loss of 
expression  of  E–Cadherin. 
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“WHO classification of tumors of stomach(19)”: 
1. Epithelial tumours 
A.Intraepithelial neoplasia  
 
B. Carcinoma which includes 
Adenocarcinoma  
-intestinal type  
-diffuse type  
Papillary adenocarcinoma  
Tubular adenocarcinoma  
Mucinous adenocarcinoma  
Signet-ring cell carcinoma  
Adenosquamous carcinoma  
Squamous cell carcinoma  
Small cell carcinoma  
Undifferentiated carcinoma  
Others 
 
C. Carcinoid  
 
2. Non-epithelial tumours 
Leiomyoma  
Schwannoma  
Granular cell tumour  
Glomus tumour  
Leiomyosarcoma  
Gastrointestinal stromal tumour 
-benign  
          -uncertain malignant potential  
          -malignant  
Kaposi sarcoma  
Others 
Malignant lymphomas 
Marginal zone B-cell lymphoma of 
MALT-type  
Mantle cell lymphoma  
Diffuse large B-cell lymphoma  
3. Secondary tumours 
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Laurens classification system: 
        Intestinal     Diffuse type 
Epidemiology High risk  areas only Even in low risk areas 
Environmental factors Present – H.Pylori Absent 
Male:Female 2:1 M=F 
Age of patients >50 years <50 years 
Anatomical site  Antrum  Fundus/body 
Growth pattern 
Exophytic, intraluminal 
mass with expansile 
growth pattern 
Ulcerative,  diffuse 
infiltrative growth pattern 
Precursor lesions 
(chronic atrophic 
gastritis, metaplasia, 
dysplasia)   
Present  Not seen always 
Microscopic features 
Well defined gland 
formation present, mucin 
within gland lumina. 
Poorly differentiated 
discohesive cells, no well 
defined glands, 
intracellular / extracellular 
mucin+. 
Prognosis Good  Poor  
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PATHOGENESIS OF GASTRIC CARCINOMA: 
The pathogenesis of gastric cancer is a complex and multifactorial 
process, which is a classical example of gene-environment interactions. The 
precise mechanism underlying this is not yet fully understood and vary 
according to the histological type of the malignancy. 
 
The majority of the cases of gastric carcinoma, are the end products of 
inflammatory cascade that progresses from superficial nonatrophic gastritis 
to gastric atrophy and can progress to intestinal metaplasia and precursor 
lesions like gastric adenoma/ dysplasia allowing to form the overt invasive 
carcinoma. The occurrence of this histological sequence of events to form 
overt gastric cancer is called as CORREA pathway. 
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This cascade which is activated by infection with the H.Pylori is 
necessary, but not sufficient enough to produce gastric cancer. Chronic 
gastritis stimulates the proliferation and transformation of the adult stem 
cells which are normally located in the isthumus of corpus glands or at the 
base of antral glands. Either of these transformed stem cells or the bone 
marrow derived stem cells which have been recruited to the gastric mucosa 
following chronic gastritis or both of which can contribute to tumor 
development. 
These oncogenically transformed stem cells are called as gastric 
cancer stem cells(GCSCs) which has similar properties of other stem cells 
such as self renewal and multipotential. 
The two major classes of genes that have been implicated in 
molecular pathogenesis of  gastric carcinoma are as follows: 
1. Genes that are related to the regulation of cell cycle like cyclin, p53 & 
cyclin dependent kinases. 
2. Genes that are related to growth signal transduction like growth 
factors and receptor tyrosine kinase. 
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Germline mutation in CDH1 gene which codes for E-cadherin protein 
that mediates epithelial intercellular adhesion, is the key step in development 
of the most familial types of gastric cancer.  
Mutations in β catenin, APC, microsatellite instability and 
hypermethylation of several genes like TGFβRII, IGFRII and p16/INK4a 
have been associated with sporadic type of gastric cancer(25). 
TUMOR SPREAD: 
Property of invasion and metastasis is considered as the “hallmark” 
for any malignant neoplasm. The loss of normal cellular adhesion plays 
significant role in human cancer invasion and metastasis.  
Gastric carcinoma can spread by direct extension, lymphatic/ 
hematogenous route or through peritoneal dissemination. Diffuse type most 
often spreads to duodenum through submucosa and subserosa via 
submucosal lymphatics and thereby to peritoneal surface. Intestinal type 
most often metastatise via hematogenous route to liver. 
Both histological types of gastric carcinoma such as intestinal and 
diffuse types have the equal incidence of lymph node metastasis which can 
spread to supraclavicular node which is then called as “Virchows node”. If it 
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involves left axillary node then it is called as “Irish’s node” or when it 
metastatise to periumblical node, called as “Sister Mary Joseph’s Node”. 
Peritoneal seedling may involve the ovaries or the cul-de-sac, later being 
called as Blumer’s shelf (26-27).  
The importance of lymphnode dissection lies in the detection of 
metastasis and appropriate tumor staging which helps in patients 
management. 
Some of the studies that have been conducted to demonstrate the clinical 
significance of lymph node involvement, noted that the extent of lymph 
node involvement was found to be significant predictor of survival. It is also 
established that the presence of tumor emboli greatly influences the tumor 
recurrence as well as survival after curative resection. 
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TNM classification of gastric tumours(19)”: 
 
T – PRIMARY TUMOUR 
TX  - Primary tumour cannot be assessed 
T0  - No evidence of primary tumour 
Tis -Carcinoma in situ (without LP invasion) 
T1 -Tumour invades lamina propria or submucosa 
T2 -Tumour invades muscularis propria or subserosa 
T3  -Tumour penetrates serosa without invasion of adjacent structures.  
T4  -Tumour invades adjacent structures such as pancreas, liver, kidney, 
spleen, colon and also retroperitoneum. 
 
N – REGIONAL LYMPH NODES 
Nx- Regional lymph nodes cannot be assessed 
N0- No regional lymph node metastasis 
N1- Metastasis in 1 to 6 regional lymph nodes 
N2- Metastasis in 7 to 15 regional lymph nodes 
N3- Metastasis in more than 15 regional nodes 
 
M – DISTANT METASTASIS 
MX- Distant metastasis cannot be assessed 
M0 - No distant metastasis 
M1 - Distant metastasis 
 
38 
 
 
STAGE GROUPING 
 
Stage 0                    Tis N0 M0 
 
Stage IA                   T1 N0 M0 
 
Stage IB                   T1 N1 M0 
                               T2 N0 M0 
 
Stage II                    T1 N2 M0 
                                 T2 N1 M0 
                                 T3 N0 M0 
 
Stage IIIA                T2 N2 M0 
                                 T3 N1 M0 
                                T4 N0 M0 
 
Stage IIIB                 T3 N2 M0 
 
         StageIV              T4 N1, N2, N3 M0 
                                  T1, T2, T3 N3 M0 
                                  Any T Any N M1 
 
 
 
  
This staging applies only to carcinoma. 
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RATIONALE OF SEARCH FOR A NEW MARKER TO PREDICT 
THE TUMOR BEHAVIOUR 
Early detection of group of patients with increased chance of  
recurrence or mortality even after curative resection would help the clinician 
to delineate such patients and offer them a more stringent post therapeutic 
monitoring and provide them a more aggressive therapeutic approach. This 
is the rationale for the search of new markers in gastric adenocarcinoma. 
Adhesion molecules are promising candidates among vast group of 
prospective markers. 
 
Cell adhesion molecule groups have been classified into 5 family of 
proteins which includes cadherins, integrins, members of immunoglobulin 
family, selectins and CD44 (31-32). 
 
Cell adhesion molecules play an important role in neoplasms since 
intracellular adhesion and interaction of malignant cells with surrounding 
extracellular matrix are crucial steps necessary for invasion and 
metastasis(33).  
 
Spreading neoplastic cells have to reduce their cohesion with primary 
tumor and reach the extracellular matrix actively, recognizing its component 
at the same time. On the other hand the tumor cells travelling within 
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vasculature (blood stream/ lymphatics) will mimic leukocytes in their 
adhesion property and adheres to the endothelial surface. Thus the spread of 
neoplasm requires a delicate balance between adhesion and anti adhesion 
(34). 
 
From the above discussion made, it has been established that, for the 
tumor invasion to occur, the cancer cells should leave the colony of primary 
tumor and enter the surrounding tissue, pass through the blood vessels and 
reach the metastatic site. At the site of metastasis, it creates the tissue 
environment that resembles the primary site.  
 
The property of migratory behaviour, that is acquired by epithelial 
tumor cells mimics that of mesenchymal cells. Variety of extracellular 
signals such as upregulation/ downregulation of certain proteins, stimulates 
the conversion of epithelial into mesenchymal cells. This striking epithelial 
plasticity has been named as “Epithelial - mesenchymal transition”.  
 
But for the establishment of metastasis at that site, the cells has to go 
through an inverse process called “Mesenchymal - epithelial transition”. 
Both these epithelial mesenchymal transition and also the mesenchymal 
epithelial transition are normal essential  mechanism during embryogenesis. 
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Cluster of differentiation 44(CD44) is a typical example of cell 
adhesion protein which undergoes erroneous structural and functional 
changes during malignant transformation. This transmembrane glycoprotein, 
functions as the principal transmembrane hyaluronate receptor (H-CAM) 
and has also been called as Phagocytic Glycoprotein-(pgp-1). 
CD44 glycoprotein is encoded by a gene located on the short arm of 
chromosome 11. It exists in different isoforms like CD44s and CD44v which  
occurs due to alternative RNA splicing.  
P53 is a tumor suppressor gene that acts as a key mediator, that 
protects the cell from various stress inducing stimuli. CD44 is repressed by 
p53 under normal circumstances, but in presence of p53 mutation as in 
carcinogenesis, CD44 expression is activated which is needed for growth 
and tumor initiating ability(41). 
CD44v interacts with glutamate cysteine transporter in gastric mucosa 
thereby regulating the reduced glutathione (GSH) synthesis. This reduced 
glutathione acts as an antioxidant to counteract the effect of reactive oxygen 
species(ROS) that are produced during chronic gastritis. Thereby high CD44 
in gastric cancer cells increases the protection against ROS and promotes the 
tumor growth(40). 
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The major form of CD44 in epithelial cells is CD44s(standard) which 
consists of extracellular domains like exons 1-5 and 16, a transmembrane 
domain(exon 18) and also a cytoplasmic domain (exon 20). CD44v(variant) 
are isoforms that are formed rather by the alternative splicing of exons 6-
15(14).  
The property of post translational modification of the cytoplasmic 
domain of CD44 by protein kinase C allows it to attach to membrane 
cytoskeleton called ankyrin, which enables the adhesion property (42). 
PHYSIOLOGICAL FUNCTION OF CD44 
CD44 was initially described as an antigen on red blood cells and 
platelets, which is now being termed as a lymphocyte homing receptor (28). 
Both the metastasizing tumor cells and recirculating lymphocytes share 
similar properties like motility and invasive behaviour, which indicates that 
tumor cells might use molecules like CD44 for metastasizing(18).  
‘THE CHARACTERISTIC’ functions of CD44 includes both the cell 
adhesion (to extracellular matrix components especially HA) and also 
homotypic cell aggregation.  
43 
 
CD44 has been called as H-CAM (Hyaluronate-cell adhesion 
molecule). Hyaluronan is seen in abundance in extracellular matrix and act 
as principle ligand for CD44, but it is not the only ligand. The other ligands 
include rest of extracellular matrix component like collagen, chondroitin 
sulphate, fibronectin and laminin.  
Stroma of most of the tumors contain increased amount of hyaluronic 
acid. Hence increased expression of CD44 by the neoplastic cells potentiates 
the tumor cells to adhere to extracellular matrix through ligands like 
hyaluronan and allows active formation of cell colonies. 
In addition, over-secretion of CD44 by tumor cells might cause the 
tumor cells to be perceived as lymphocytes by the immune system, which 
might trigger the occurrence of immune escape (13). CD44 thus secreted 
binds to HA, and during the transport of HA, it also intervenes in the 
transportation of tumor cells into the lymphatic flow (11). 
 
CD44 also functions as a putative cancer stem cell surface marker and 
henceforth can be used as a novel therapeutic target. CD44 has the property 
to internalize hyaluronan and therefore can act as a target receptor for 
44 
 
hyaluronan-conjugated drugs, nanocarrier delivery systems, or for anti-
CD44 antibodies linked to radioactive isotope or chemotherapeutic agents. 
An increased levels of soluble CD44 was found in the serum of 
patients with gastric carcinoma which may be used as a prognostic indicator 
of tumor burden and metastasis in such cases(47).  
The different methods for evaluating the presence and degree of CD44 
expression includes immunocytochemistry, which helps to detect the  
localisation of CD44 molecule in tissues, others being fluorescence cell 
sorting and reverse transcriptase polymerase chain reactions which will help 
in quantitative analysis by measuring mRNA levels of  CD44.  
OZMEN F et al (13) studied tissue samples from 33 patients (8 
females) with gastric cancer. Quantitative and qualitative analysis of the 
following markers like LYVE-1, VEGFR-3 and CD44 were analyzed by 
both RT-PCR and IHC. 64% of cases showed CD44 positivity. No 
correlation was made between CD44 expression and age, sex data’s. CD44 
expression was showing significant statistical correlation with histological 
type, grade and stage of the tumor. Increased expression of CD44 was 
associated with increased risk of metastasis and poor survival in this study. 
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YUTA WAKAMATSU Y (15) and his colleagues evaluated a total of 
190 cases of gastric carcinoma. They analyzed  the expression of cancer 
stem cell markers like ALDH1, CD44, and CD133 in both the primary 
tumors as well as in lymph node metastasis of gastric cancer by 
immunohistochemical method.  
 
Out of 190 primary gastric carcinoma cases studied, 117(62%) were 
positive for CD44 and rest of the two markers showed less apparent 
expression compared to CD44.  
 
Expression of all the three cancer stem cell markers studied showed 
significant correlation with advanced clinicopathologic factors.  
 
Patients with both CD44 and CD133 positive gastric carcinoma had a 
poorer survival rate than the patients with both markers negative.  CD44 
expression and CD133 expression are considered as independent predictors 
of survival in patients with gastric carcinoma(15) 
HAMID et al (36) studied 100 cases of gastric adenocarcinoma for its 
expression of CD44 by immunohistochemistry. 65% of tumors were CD44 
positive, which were most commonly associated with intestinal type of 
tumors. A strong statistical significance was seen to exist between CD44 
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expression and the histological grade of tumor. CD44 positive tumors 
showed poorer survival . 
 
STREIT M et al (37) in their study identified that, occurrence of the 
CD44 standard and the CD44-9v isoform on the gastric cancer cells was 
significantly associated with higher tumor-induced mortality and also shorter 
survival time. The intestinal-type of gastric carcinomas shows high CD44v6 
expression. 
 
YOON H KO et al(38) reviewed 159 cases of non small cell lung 
cancer. He investigated CD44s protein expression in 159 cases by using 
tissue array. High CD44s expression was detected more with squamous cell 
carcinoma (91.7%) than in those with adenocarcinoma histology.  
 
XIN, YAN M.D (39) and his other expertise colleagues  reviewed 
nearly 150 cases of gastric adenocarcinomas of which 100 were advanced 
gastric cancers, 36 were early gastric cancers and the rest were of 
intermediate category. CD44V6 expression was studied using 
immunohistochemistry. Increased expression was showing strong 
association with advanced cases and also lower survival rate.  
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SHA L et al analysed the rate and mean fluorescence intensity of 
CD44 cells by flow cytometry. In gastric carcinoma, increase in CD44 
protein indicates its major role in the invasion and metastasis of gastric 
carcinoma. 
 
MAYER B  (40) and his colleagues attempted to study the prognostic 
value of CD44 in gastric adenocarcinoma. They evaluated both benign (59) 
and malignant (primary 61, metastatic 59) gastric tissue for its expression for 
monoclonal antibodies against CD44. CD44 negative in normal mucosa and 
shows positivity only in malignant tissue. 49% of cases showed CD44 
positivity which was expressed more in cases of primary tumor who 
underwent curative resection.  
 
CD44 positive cases showed increased tumor recurrence and 
increased mortality during follow-up. Good correlation was made out 
between the expression of total CD44 and  tumor recurrence and mortality. 
 
CHANG HAK YOO M et al(41) conducted a  prospective study of 
total of 261 cases of  gastric carcinomas. Tissue samples from all the cases 
were stained with the monoclonal antibodies against both CD44 and nm23 
by IHC method. 43.2% of cases showed CD44 positivity. Significant 
difference in five year survival rate was made between CD44-positive and 
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negative cases (P = 0.0018). However, there was no such difference seen 
between  patients with nm23-positive and negative cases. 
CHING-SHYA YONG (42) and his colleagues conducted a 
retrospective study.  They reviewed the hospital records of 500 patients with 
gastric cancer who underwent surgical resection. Out of 500 patients, 95 
patients developed recurrence post operatively. Twenty patients from the 
recurrence group and 20 patients from the non-recurrence group were 
randomly selected and identified as study and control groups, respectively.  
They analysed expression of  both CD44 and CD24 protein in both the 
groups by immunohistochemistry. The study revealed that the expression of 
CD44 protein was significantly correlated with stage of the tumor than that 
of CD24. 
KARL-HEINZ HEIDER et al (43) evaluated 42 cases of gastric 
adenocarcinomas for CD44 expression by IHC. Study revealed that  
adenocarcinomas of the intestinal type were strongly positive for CD44v6, 
whereas diffuse-type adenocarcinoma showed CD44v5. Analysis of RNA 
expression confirmed the data obtained with immunohistochemistry. These 
differences in expression was attributed to different origins of these tumor 
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types. It was concluded that CD44 can be used as a tool in gastric cancer 
prognosis. 
YOO, C. H et al (44) and his team studied about a total of 261 cases 
of gastric carcinomas considering only stage II and stage IIIA. 
Immunohistochemical evaluation of tissue samples by staining with the 
monoclonal antibodies against CD44 and nm23. Of 261 cases studied 31.0% 
were CD44 positive and 70.1% showed nm23 positivity.  
No significant association was made between CD44 expression and 
clinicopathological variables. But the 5-year survival rates between CD44-
positive and negative cases was found to be significant (P = 0.0018).  
SADHNA DHINGRA et al (45) and the team members evaluated the 
expression of cancer stem cell markers like CD44 and nestin in both 
neoplastic and also in non-neoplastic gastric tissue. Tissue microarray was 
structured by tissue samples obtained from 174 cases of gastric 
adenocarcinoma and 41 samples of adjacent non neoplastic gastric mucosa. 
Clinical data’s were procured. Expression of CD44 and nestin were assessed 
by immunohistochemistry. The study revealed 51% (78/152) of CD44 
positivity and 25% (43/174) of nestin positivity. CD44 positivity was 
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significantly greater in gastric adenocarcinoma (P<0.001) and more 
frequently associated with Lauren’s intestinal histologic subtype (P<0.05). 
 
YAMAGUCHI  et al (46) found that the expression of CD44v6 
protein was significantly higher in differentiated adenocarcinoma than in 
diffuse-type carcinoma. 
 
SAITO et al (47) observed in his study that high CD44v6 expression 
is seen in association with intestinal-type gastric carcinoma.  
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IMMUNOHISTOCHEMISTRY 
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IMMUNOHISTOCHEMISTRY 
 
Immunohistochemistry as the name suggests, involves the principles 
of two divisions which are nothing but immunology and histology. It is 
defined as the technique for identifying antigens by means of antigen-
antibody interaction, the site of interaction being detected by either primary 
labeling of the antibody or by secondary labeling method. (35) 
 
This technique determines whether the tissue under study expresses a 
particular antigen and in addition to that it also determines the antigenic 
status of particular cells within that tissue and its cellular location by which 
it  identifies the biology and lineage specificity(36). 
 
The key to immunohistochemistry is the specificity of antibodies for 
particular antigens. The subjectivity which is common in any surgical 
pathology diagnostic procedures may lead to common problem of lack of 
reproducibility among the pathologists.  
 
Much of the variations in immunohistochemical test results are mainly 
due to irregularities in specimen handling, particularly fixation. It is 
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generally noted that many of the antigens are severely affected by long 
duration of fixation. It is commonly advised that the duration of fixation 
(standard is formalin fixative) must be restricted to a maximum of 24 hours.  
 
It has been emphasised that the immunohistochemical studies  done in 
absence of proper controls are considered of no value and could even be 
dangerous. Any departure from the protocol which is recommended by the 
manufacturer, necessitated the revalidation of whole technique by the 
performing laboratory. 
 
Detection system (35) 
 
 Antibodies are labeled to allow visualization of the site of reaction- 
which include fluorescent substances(fluorescent microscopy), enzyme 
labels (eg. Horse radish peroxidase) forming colored reaction with suitable 
substrate(light microscopy) , heavy metals (electron microscopy) and even 
radiolabels but requires autoradiographic facilities. 
 
The different techniques of  immunohistochemistry is as follows: 
1. TRADITIONAL DIRECT TECHNIQUE – Primary antibody is 
directly conjugated with the label which then binds with the antigen in 
the tissue. 
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2. NEW DIRECT TECHNIQUE( ENHANCED POLYMER ONE 
STEP STAINING METHOD)- Here the large number of primary 
antibodies and enzyme labels are tagged to a dextran polymer which 
acts as backbone which increases the signal and better sensitivity of 
the test. 
 
3. TWO -STEP INDIRECT TECHNIQUE- Here the secondary 
antibody will be labeled against the immunoglobulin of the animal 
species in which primary antibody been prepared.  This is more 
sensitive than the direct method in detecting antibodies. 
 
4. UNLABELLED ANTIBODY-ENZYME COMPLEX 
TECHNIQUE (Peroxidase-Antiperoxidase complex) 
 
5. IMMUNOGOLD SILVER STAINING TECHNIQUE- This is 
used in ultrastructural immunolocalisation. Gold particles are 
enhanced by the addition of several layers of metallic silver. 
 
6. STREPT(AVIDIN)-BIOTIN TECHNIQUE- Here avidin is 
conjugated with secondary antibody and similarly biotin  with the 
primary antibody has been used  based on the fact of existence of  
high affinity binding between both avidin and biotin. 
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7. HAPTEN  LABELLING TECHNIQUE. 
 
Different methods of antigen retrieval techniques has been demonstrated 
which includes, 
1. Proteolytic enzyme digestion method 
2. Microwave antigen retrieval method 
3. Pressure cooker antigen retrieval method 
4. Water bath method. 
These techniques allow unmasking of antigens which was happened during 
fixation.  
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MATERIALS AND METHODS 
PATIENT SELECTION: 
The protocol for this study was reviewed and approved by the 
Institutional Ethical committee, Govt. Stanley Medical College, Chennai. 
Data was obtained retrospectively from registers which include the patients 
data who underwent gastrectomy (subtotal/total) for gastric cancer from 
August 2011 to August 2012. A retrospective review of patient’s medical 
records was obtained and data were collected for age, sex, presenting 
symptoms, socioeconomic status (assessed by occupation, literature and per 
capita income), risk factors like smoking, alcohol and tobacco chewing (50) 
and also the final pathologic diagnosis with the help of prestructured 
proforma.  
Tumors were classified histologically according to the WHO criteria 
and was staged according to TNM staging; Lauren’s classification system  
was applied for histological typing of tumor (intestinal type gastric cancer 
corresponds to well- or moderately differentiated tumors; diffuse type 
corresponds to poorly differentiated tumors). 
Clinical history and investigation findings were tabulated.  
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STUDY DESIGN- Longitudinal retrospective study. 
 
EXCLUSION CRITERIA: 
1. Non adenocarcinoma cases. 
2. Patients who underwent preoperative chemotherapy. 
INCLUSION CRITERIA: 
Fifty patients with histologically verified diagnosis of gastric 
adenocarcinoma were randomly (cases with complete clinical data) selected 
as subjects in my study and was retrospectively analyzed for CD44 
expression in patient’s post-operative pathologic specimens.  
TISSUE PREPARATION 
Formalin fixed paraffin embedded blocks of the cases of gastric 
adenocarcinoma included in this study were taken. H&E sections of these 
cases were reviewed and analysed both for grading and staging.  Appropriate 
blocks were chosen for further evaluation of CD44 IHC staining.  
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IHC was done by HRP polymer technique. 
1. Chrom alum coated slides were prepared for IHC examination and 
4 micron thick sections were taken in chrom alum coated slides 
and incubated for atleast 2 hours. 
2. After paraffin removal and rehydration, antigen retrieval was 
performed by placing sections into a beaker containing adequate 
amounts of citrate buffer (pH 6.0), then heating in microwave oven 
for 15 minutes and cooling to room temperature. 
3. Peroxidase block was added for 30 minutes, for inhibiting 
endogenous peroxidase in the tissue. 
4. Sections were washed in TRIS buffer for 5 minutes. 
5. Power block was applied for 30 minutes which blocks non specific 
antigen antibody reaction. 
6. Excess power block was blotted. 
7. Primary antibody (mouse anti-CD44 monoclonal antibody, clone 
DF1485 which identifies all isoforms of CD44) was applied for 60 
minutes. 
8. Washed in TRIS buffer for 5 minutes twice. 
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9. Applied super enhancer for 30 minutes which enhances the final 
reaction product by increasing the sensitivity of antigen antibody 
reaction. 
10. Secondary antibody was then added for 15 min, followed by TRIS 
buffer washing . 
11. DAB substrate solution was subsequently added and washed with 
running water followed by hematoxylin counterstaining. 
12. Finally, tissue sections were washed with distilled water, 
dehydrated and mounted for microscopic evaluation. 
13. IHC analysis was done for all cases and scored for each case. 
Tonsillar tissue was used as positive control and in CD44 negative cases, the 
tumor infiltrating lymphocytes present in neoplasm was used as internal  
positive control and normal gastric tissue  was used as negative control. 
Scoring technique was as follows- For the interpretation of CD44 
expression in the tissue, both the staining intensity and percentage of 
staining area were considered. 
 
 
 
 
1. Intensity of staining was scored as follows: 
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 (0)= No staining 
 (1+)= Weak staining 
 (2+)= Moderate staining 
 (3+)= Strong staining 
2. The percentage of staining area was scored accordingly : 
0= 0%;  
1=when 1-10% of the area gets stained, 
2=when more than 10%, but upto 50% of the tumor shows staining,  
3=more than 50% but upto 100% of the tumor are being stained.  
Composite score was obtained by multipying both the intensity of 
staining as well as the percentage of staining. The composite score ranges 
from 1 to 9. Composite scores of 1-3 was labelled as ‘low CD44 expression’, 
whereas scores of 4-9 were labelled as “high CD44 expression”.  
Tumors with both weak and moderate / strong staining is regarded as 
positive expression, while those with negative staining only is considered 
as negative expression.  
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 Statistical analysis were performed to correlate between the CD44 
expression status and clinical variables such as age, sex, socioeconomic 
status, risk factors like smoking, alcohol and tobacco chewing, location of 
tumor and also histologic parameters like histological type, grade and stage. 
Results were tabulated and statistical significance analysed for necessary 
variables such as CD44 expression against histological type, grade and 
stage. P value of less than 0.05 was considered statistically significant. 
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Table 1. Age And  Sex Distribution In Gastric Adenocarcinoma 
 
 
AGE 
 
MALE 
 
FEMALE 
TOTAL 
NUMBER 
OF CASES Number of cases Number of cases 
0-20 0 0 0 
21-40 2 2 4 
41-60 12 6 18 
>60 20 8 28 
TOTAL 34 16 50 
 
 
Out of 50 cases of gastric adenocarcinoma studied 34(68%) were males and 
16(32%) were females with Male:Female sex ratio accounting to  2.1:1. 
Among the 50 cases studied, majority (56%) were in the age group of  above 
60 years and gastric adenocarcinoma was found to be more prevalent among 
people above 60 years. 
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Table 2. Presenting symptoms of 50 cases (gastric adenocarcinoma) 
 
SYMPTOMS NUMBER OF CASES 
PERCENTAGE OF 
CASES(%) 
DYSPEPSIA 47 94 
EPIGASTRIC PAIN 40 80 
VOMITING 12 24 
MALENA 4 8 
 
Dyspepsia, followed by epigastric pain was found to be the common 
presenting symptoms seen in majority of cases. Vomiting was seen in most 
of the advanced stages of cancer. Malena was found in cases with ulcerative 
tumor morphology. 
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Table 3. Socioeconomic Status Of 50 Patients Presented With Gastric 
Adenocarcinoma 
 
SOCIOECONOMIC STATUS NUMBER OF CASES 
LOWER 7 
UPPER LOWER 40 
LOWER MIDDLE 2 
UPPER MIDDLE 1 
UPPER 0 
TOTAL 50 
 
Out of 50 cases, majority of (80%) patients belonged to lower socio 
economic status. 
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Table 4. Assessment Of Risk Factors Like Smoking, Alcohol Intake, 
Tobacco Chewing In 50 Cases Studied 
 
RISK FACTORS MALE FEMALE 
SMOKING 8 0 
ALCOHOL 12 0 
TOBACCO 5 6 
 
Of the 50 cases evaluated smoking and alcohol appears as major factors in 
males. Tobacco chewing was significantly associated with female 
population. Tobacco chewing was included in the list to demonstrate the 
association of it with gastric carcinoma, as smoking and alcohol among 
females was not so common in South Indian countries. 
 
 
 
 
68 
 
Table 5. Anatomical  Distribution Of Gastric Adenocarcinoma With 
Respect to Sex distribution In The 50 Cases 
 
SITE FEMALE MALE TOTAL 
CARDIA 2 9 11 
FUNDUS AND 
BODY 
5 
 
13 
18 
ANTRUM 9 12 21 
 
 
Out of 50 cases, predominant number(21) of cases showed tumor at the site 
of antrum, followed by body/fundus(18) and least number of cases seen in 
cardia(11) region. No significant association was made between anatomical 
location of tumor with respect to sex of the patients. 
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Table 6-Tumor morphology in 50 cases of gastric adenocarcinoma 
 
 
TUMOR MORPHOLOGY NO. OF CASES 
PROLIFERATIVE 41(82%) 
INFILTRATIVE 9(18%) 
 
Most of the tumors in the present study showed ulceroproliferative  growth 
than compared to infiltrative tumor morphology. 
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Table 7. Histological Type Of Gastric Adenocarcinoma (Laurens 
Classification) 
 
HISTOLOGICAL TYPE NUMBER OF CASES % OF CASES 
Intestinal type 43 86 
Diffuse type 7 14 
Total 50 100 
 
Among the 50 cases studied, 43 of them showed intestinal type and 7 of 
them showed diffuse type- indicating the predominant pattern of 
adenocarcinoma being intestinal type. 
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Table 8. Histopathological Grading Of 50 Cases Of Gastric 
Adenocarcinoma In This Study 
 
GRADING NO. OF PATIENTS % OF CASES 
WELL 
DIFFERNTIATED 
7 14 
MODERATELY 
DIFFERENTIATED 
31 62 
POORLY 
DIFFERENTIATED 
12 24 
TOTAL 50 100 
 
Histological grading of  gastric adenocarcinoma  in these 50 cases revealed 
31 cases with moderately differentiated adenocarcinoma, followed by poorly 
differentiated tumors accounting to number of 12 cases and only 7 showed 
well differentiated carcinoma. 
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Table 9. TNM Staging Of Gastric Adenocarcinoma Cases In This Study 
 
HISTOLOGICAL STAGE NO. OF CASES % OF CASES 
Stage I 10 20 
Stage II 11 22 
Stage III 25 50 
Stage IV 4 8 
  
 
Histological staging of gastric adenocarcinoma  in these 50 cases revealed 
25 cases in stage III, 11 cases in stage II and 10 cases in stage I cancer. 4 
cases were found to be stage IV. This implies that most of the cases when 
they present with signs and symptoms has already been in advanced stage. 
 
 
 
Table 10. Histological grade versus Stage in  50 cases 
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 DIFFUSE TYPE INTESTINAL TYPE 
WELL 
DIFFERENTIATED 
0 7 
MODERATELY 
DIFFERENTIATED 
0 31 
POORLY 
DIFFERENTIATED 
7 5 
TOTAL 7 43 
 
Almost all the diffuse type(7) of gastric carcinoma was poorly differentiated, 
whereas intestinal type showed all three differentiation viz. well / moderate / 
poor in varying proportions. 
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Table 11. CD44 Expression In 50 Cases Of Gastric Adenocarcinoma 
 
 
TOTAL NO. 
OF CASES 
NO. OF CASES % OF CASES 
CD44 
POSITIVE 
43 86 
CD44 
NEGATIVE 
7 14 
 
 
Out of 50 cases, 43 cases showed CD44 positive expression and 7 showed 
negativity to CD44. 
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Table 12. CD44 Expression In 50 Cases Of Gastric Adenocarcinoma 
 
  CD44 
EXPRESSION 
NUMBER OF CASES PERCENTAGE OF CASES 
NEGATIVE 7 14 
LOW 
EXPRESSION 
23 46 
HIGH 
EXPRESSION 
20 40 
 
  
Out of 43 CD44 positive cases, 23 cases showed low expression and rest of 
20 cases showed high expression. 
 
 
76 
 
Table 13. Pattern Of CD44 Expression In Positive Cases 
 
 
CD44 POSITIVE CASES 
LOW CD44 EXPRESSION HIGH CD44 EXPRESSION 
CYTOPLASMIC MEMBRANOUS BOTH CYTOPLASMIC MEMBRANOUS BOTH 
9 12 2 0 15 5 
 
Majority of the CD44 positive cases showed predominantly membranous 
pattern of staining, some showing cytoplasmic positivity and few shows 
both membranous and cytoplasmic staining. High number of membranous 
positive cases were seen among cases showing high CD44 expression. 
 
 
 
Table 14. CD44 expression in relation to age and sex 
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AGE 
GROUP 
 
CD44 EXPRESSION 
Male Female 
Positive Negative Positive Negative 
0-20 0 0 0 0 
21-40 2 0 2 0 
41-60 10 2 5 1 
>60 17 3 7 1 
 
No significant correlation was seen between CD44 expression with respect 
to age and sex distribution among gastric carcinoma. 
 
 
 
 
 
 
 
Table 15. CD44 expression vs anatomical location of gastric carcinoma 
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ANATOMICAL SITE 
CD44 
POSITIVE NEGATIVE 
CARDIA 9 2 
FUNDUS AND BODY 15 3 
ANTRUM 19 2 
 
 
 
 
 
 
 
Table 16. CD44 Expression Vs Histological Type 
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HISTOLOGICAL 
TYPE 
CD44 EXPRESSION 
NEGATIVE LOW HIGH 
INTESTINAL 6 17 20 
DIFFUSE 1 6 0 
 
 
CD44 expression is found to correlate significantly with intestinal type of 
gastric adenocarcinoma. The P value is 0.049 which is statistically 
significant. 
 
 
Table 17. CD44 Expression Vs Histological Grade 
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CD44 
EXPRESSION 
 
HISTOLOGICAL GRADE 
 
WELL 
DIFFERENTIATED 
 
MODERATELY 
DIFFERENTIATED 
 
POORLY 
DIFFERENTIATED 
HIGH 
EXPRESSION 
7 13 0 
LOW 
EXPRESSION 
0 15 8 
NEGATIVE 0 3 4 
 
CD44 expression was high in almost all cases of well differentiated 
adenocarcinoma, instead most of  poorly differentiated tumors show low or 
negative expression only. The P value for this was 0.000 which was highly 
significant. 
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Table 18. CD44 Expression Vs Histological Stage 
 
 
HISTOLOGICAL 
STAGE(TNM) 
CD44 EXPRESSION 
NEGATIVE LOW HIGH 
NO. OF CASES NO. OF CASES NO. OF CASES 
STAGE 1 0 0 10 
STAGE 2 0 5 6 
STAGE 3 4 17 4 
STAGE 4 3 1 0 
 
In the 50 cases analyzed, almost all the stage 1 tumors showed high 
expression, and most (3/4) of stage 4 tumors showed negative expression. 
The P value for this was 0.000 which was statistically significant. 
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Table 19. CD44 expression in relation to both histological grade and 
stage 
 
CD44 
EXPRESSION 
STAGE GRADE 
I II III IV WELL DIFF. 
MOD. 
DIFF. 
POORLY 
DIFF. 
NEGATIVE 0 0 4 3 0 3 4 
LOW 0 5 17 1 0 15 8 
HIGH 10 6 4 0 7 13 0 
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Total gastrectomy-Diffuse tumor involving the entire thickness. 
 
 
 
Total gastrectomy specimen- proliferative growth in corpus 
 
 
Bx.No. 
1852/11 
Bx. No. 
3205/11 
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Total gastrectomy specimen-infiltrating tumor involving antrum. 
 
 
 
 
Bx. No. 
373/12 
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H&E-10X- Well differentiated adenocarcinoma-glands lined by 
neoplastic cells. Also seen are tumor infiltrating lymphocytes 
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H&E-10X-Moderately differentiated adenocarcinoma-showing solid 
areas along with areas of gland formation. 
 
 
 
H&E-10X-Poorly differentiated adenocarcinoma- in solid sheets. 
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40X -Lymphocytes in the tonsil(control) with strong CD44 positivity. 
 
 
40X- CD44 negative  in tumor glands but  positive in in tumor 
infiltrating  lymphocytes  (internal positive control) 
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40X- High membranous expression of CD44 in tumor gland. 
 
 
40X- Low membranous CD44 positivity in tumor glands. 
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40X- Both membranous and cytoplasmic CD44 positivity in tumor 
glands. 
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DISCUSSION 
Gastric carcinoma is one of the leading cause of death worldwide. It is 
commonly seen after 40 years of age. Males are affected more than females. 
Risk factors that are very commonly seen in association with gastric 
carcinoma include lower socioeconomic status, smoking and alcohol 
consumption. Gastric antrum is the commonest site of tumor. 
In accordance with this fact, the present study of 50 cases of gastric 
adenocarcinoma shows gastric carcinoma among the age range of 23 to 76 
years with mean age of 49.5 years. Increased prevalence of gastric 
carcinoma was seen among the age group of more than 60 years( 56%). 
Male/Female ratio of 2.1:1 was noted. 
 Significant association with lower socioeconomic status (80% 
belongs to lower socioeconomic status) as well as smoking and alcohol was 
also seen. This is due to the prevalence of H.Pylori infection in people of 
lower socioeconomic status. Most common presenting symptoms were 
dyspepsia (94%) and epigastric pain (80%).  
Vomiting  was seen in patients with advanced gastric carcinoma of 
proliferative (intestinal) type producing obstructive symptoms. 
In most cases the tumors were located predominantly in antrum (42%). 
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Similar studies conducted in India showed the following results and were 
compared with the present study. 
STUDIES 
AGE 
GROUP 
SEX 
SITE OF 
TUMOR 
SES 
Chittukadu 
et al 
55-64 years M>F 
Distal 
stomach 
LOWER 
Rajesh P et 
al 
48 years M>F 
Distal 
stomach 
LOWER 
Bryan J et al >40 years M>F 
Distal 
stomach 
LOWER 
Jijo 
velliyappillil 
cherian et al 
>40 years 
M>F with 
M:F=2.74:1 
Antrum LOWER 
Present 
study 
23-76 years 
(>60) 
M(68%)>F 
with 
M:F=2.1:1 
Antrum(42%)  LOWER 
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The histopathological parameters like histological type, grade and 
stage were also evaluated in the present study. It showed that intestinal  
type(86%) is more common than diffuse type which could be explained by 
its high prevalence in high risk regions. This study also showed increased 
occurence of moderately differentiated adenocarcinoma ( 62%) and most of 
them were reported to be Stage 3( 50%).  
 
Despite the lack of standardization and documented interobserver 
variation in the assessment, the histological grade has been shown repeatedly 
by multivariate analysis to be a stage-independent prognostic factor and it 
does not have any correlation with age or sex. In this study also there was no 
significant correlation of age and sex with histological grade of the tumor. 
 
In view of better management / prediction of prognosis of the patients 
with gastric adenocarcinoma, development of new molecular biomarkers is 
necessary to assess the outcome of those patients so that the surgeons would 
manage them with intense therapeutic regimens ( either medical/ surgical). 
 
All the 50 cases which were included in present study were evaluated 
for CD44 expression which is considered as novel biomarker for assessing 
metastasis and prognosis. 
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The present study showed 86% of CD44 positive cases of which 46% 
were showing low expression. CD44 expression showed significant 
correlation with histological type (intestinal)[p value=0.049], histologic 
grade (well differentiated)[p value=0.000] and also histological stage (1,2) 
[p value= 0.000]. 
Similar studies which were conducted showed  the following results. 
In a study conducted by Kamran ghaffarzadehgan et al, out of 100 
patients studied of gastric carcinoma, 65% of cases were CD44 positive. It 
was commonly seen in intestinal subtype (p=0.002). Statistical correlation 
was also significant between CD44 expression and grade of the tumor 
(p=0.014). It was correlated with poor prognosis with grave survival benefit 
(p=0.008). No significant correlation was seen with clinical variables. 
 
 In another study conducted by Twang et al (43), where 116 cases of 
gastrectomy specimens of gastric carcinoma were analyzed . IHC expression 
of stem cell markers like CD44, Musashil and CD133 in gastric tissue 
samples were analysed. 77% of cases showed CD44 positivity. In this study 
no difference in expression of CD44 between intestinal and diffuse type was 
observed. But significant statistical correlation was seen between 
histological stage and grade of the tumor(p=0.002). 
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Since CD44 expression has shown a significant association with the 
stage of the disease and since the stage is a proven prognostic marker in 
gastric adenocarcinomas, CD44 expression can be used as a prognostic 
marker to assess the invasiveness and also the metastatic potential of these 
tumors. 
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SUMMARY AND CONCLUSION 
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SUMMARY 
 
In this study, 50 cases of gastric adenocarcinoma were taken 
randomly, which was diagnosed from the tissue sections obtained from 
total/subtotal gastrectomy specimens received in our Department of 
Pathology. The cases with an adequate clinical and investigation data have 
only been included in the study.  
 
The age group in gastric adenocarcinoma cases were ranging between 
23 to 76 years with the peak age of occurrence in the age group of more than 
60 years(56%). Males were affected commonly than females(male/female 
ratio=2.1:1). Most common presenting symptoms were dyspepsia(94%) and 
epigastric pain(80%) and small proportion of patients also presented with 
symptoms of vomiting(24%). Majority of cases of gastric carcinoma have 
significant association with smoking and alcohol. 
Oesophagogastroduodenoscopy findings of most of the tumors were found 
to be proliferative growth(82%) 
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The tumors were graded as well differentiated, moderately 
differentiated and poorly differentiated and also staged according to TNM 
system. High number of cases were found to be moderately differentiated 
tumors and also predominantly found to be in stage 3  at the time of 
diagnosis. 
 
CD44 expression was studied by immunohistochemistry in all the 50 
cases. Scores were given for the intensity of staining as well as for the 
percentage of tumor cells stained and composite scores for each case has 
been analyzed. Composite score was calculated by multiplying both the 
intensity and percentage of tumor cells stained by IHC. Cases were divided 
into positive and negative for CD44 expression. The CD44 positive cases 
were further divided by its pattern of positivity as membranous, cytoplasmic 
or both membranous and cytoplasmic. 
 
By statistical analysis CD44 expression was found to show significant 
correlation with histological type, grade as well as stage, but showed no 
significant correlation with age, sex and gross findings such as location and 
morphology of the tumor in resected specimens. 
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Three cases of moderately differentiated adenocarcinoma showed 
negative expression for CD44, which may be explained by advanced stage 
(stage 4) of the tumor in these cases and can also be attributed to tumor 
heterogeneity within the same tumor. 
 
Limitation of the study: 
As the study has been conducted in smaller sample it needs to be evaluated 
in larger samples for better evidence of correlation of CD44 versus clinical 
and histopathological findings. 
 
Scope for future study: 
In the future CD44 could further be used for targeted therapy in patients with 
gastric adenocarcinoma. 
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S.NO BIOPSY NO. AGE/SEX SITE   GROSS HISTOLOGICAL TYPE   GRADE
1  548/11 35/M Body Proliferative Intestinal Moderately differentiated
2  609/11 44/M Cardia Ulcerative Intestinal Well differentiated
3  716/11 48/F Cardia Proliferative Intestinal Moderately differentiated
4 1222/11 70/M Body Proliferative Intestinal Moderately differentiated
5 1805/11 66/M Cardia Proliferative Intestinal Poorly differentiated
6 1852/11 62/M Body Ulcerative Diffuse Poorly differentiated
7 1866/11 74/F Body Ulcerative Diffuse Poorly differentiated
8 2000/11 72/M Cardia Ulcerative Intestinal Moderately differentiated
9 2033/11 67/M Body Ulcerative Diffuse Poorly differentiated
10 2086/11 48/F Antrum Proliferative Intestinal Moderately differentiated
11 2095/11 52/M Body Ulcerative Diffuse Poorly differentiated
12 2132/11 44/F Antrum Proliferative Intestinal Moderately differentiated
13 2247/11 67/M Body Proliferative Intestinal Moderately differentiated
14 2255/11 49/M Antrum Proliferative Intestinal Moderately differentiated
15 2298/11 58/F Body Ulcerative Diffuse Poorly differentiated
16 2311/11 66/M Antrum Proliferative Intestinal Moderately differentiated
17 2345/11 76/F Body Ulcerative Diffuse Poorly differentiated
18 2464/11 72/F Body Proliferative Intestinal Moderately differentiated
19 2474/11 44/M Body Proliferative Intestinal Moderately differentiated
20 2843/11 72/F Antrum Proliferative Intestinal Moderately differentiated
21 3043/11 54/M Antrum Proliferative Intestinal Poorly differentiated
22 3078/11 36/F Antrum Proliferative Intestinal Moderately differentiated
23 3205/11 67/M Antrum Proliferative Intestinal Moderately differentiated
24 3206/11 56/F Antrum Proliferative Intestinal Moderately differentiated
25 3363/11 63/F Antrum Proliferative Intestinal Moderately differentiated
26 3371/11 52/M Antrum Proliferative Intestinal Moderately differentiated
27 3523/11 68/M Cardia Proliferative Intestinal Moderately differentiated
28 3613/11 46/M Body Ulcerative Diffuse Poorly differentiated
29 3997/11 39/M Antrum Proliferative Intestinal Moderately differentiated
30 4051/11 62/M Body Proliferative Intestinal Moderately differentiated
31 4308/11 61/M Body Proliferative Intestinal Moderately differentiated
32 4313/11 72/F Body Proliferative Intestinal Poorly differentiated
33 4359/11 76/M Antrum Proliferative Intestinal Moderately differentiated
34 4386/11 65/M Antrum Proliferative Intestinal Moderately differentiated
35 4673/11 63/M Antrum Proliferative Intestinal Moderately differentiated
36 5039/11 38/F Antrum Proliferative Intestinal Moderately differentiated
37 5101/11 68/F Antrum Proliferative Intestinal Moderately differentiated
38 5924/11 66/F Antrum Proliferative Intestinal Moderately differentiated
39 6032/11 71/M Antrum Proliferative Intestinal Moderately differentiated
40 6423/11 56/M Antrum Proliferative Intestinal Moderately differentiated
41    37/12 59/M Body Proliferative Intestinal Moderately differentiated
42  373/12 46/F Cardia Proliferative Intestinal Well differentiated
43  502/12 48/M Cardia Proliferative Intestinal Well differentiated
44  530/12 70/M Body Proliferative Intestinal Poorly differentiated
45  698/12 69/M Cardia Proliferative Intestinal Well differentiated
46  752/12 67/M Antrum Proliferative Intestinal Moderately differentiated
47 1338/12 71/M Cardia Proliferative Intestinal Well differentiated
48 1427/12 59/M Cardia Proliferative Intestinal Well differentiated
49 1661/12 48/M Body Proliferative Intestinal Poorly differentiated
50 2222/12 63/M Cardia Proliferative Intestinal Well differentiated
STAGE CD44 EXPRESSION
3 Low expression
1 High expression
3 Low expression
3 Low expression
3 Negative
4 Low expression
3 Low expression
3 High expression
3 Low expression
3 Low expression
4 Negative
3 Low expression
1 High expression
3 Low expression
3 Low expression
3 Low expression
3 Low expression
3 High expression
3 Low expression
3 Negative
3 Low expression
3 Low expression
2 Low expression
3 Negative
2 Low expression
2 Low expression
3 Negative
3 Low expression
2 Low expression
2 Low expression
3 High expression
3 Low expression
3 High expression
2 High expression
2 High expression
2 High expression
2 High expression
3 Low expression
2 High expression
1 High expression
1 High expression
1 High expression
1 High expression
4 Negative
1 High expression
2 High expression
1 High expression
1 High expression
4 Negative
1 High expression
